中医药治疗非酒精性脂肪性肝病的优势与展望
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然基金面上项目(编号:81374031,81173404)


Advantages and Prospects of Traditional Chinese Medicine in Treating Nonalcoholic fatty liver disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目前非酒精性脂肪性肝病的西医治疗手段与不断升高的发病率呈不相吻合的趋势。在临床治疗中,中医药占重要一席之地。作者认为,中医药治疗非酒精性脂肪性肝病的主要优势点在于:1)临床运用广泛且具疗效;2)中药多途径的治疗效应与疾病的复杂机理相对应;3)抑制炎症、保肝降酶效应显著。并在如何开展临床研究;从调节肠道菌群、抗肝纤维化、以及中药组分复方方面开展基础研究提出了设想和展望。

    Abstract:

    Currently, there is a mismatch between the limited treatments of western medicine and the rising incidence rate of nonalcoholic fatty liver disease(NAFLD). Traditional Chinese Medicine(TCM) is now playing an important role in the clinical treatment of liver diseases including NAFLD. In this article, we review the main advantages of TCM in treating NAFLD as follows:1)TCM is widespread used and shown the efficacy in clinic;2)The multi-path effect of TCM corresponds to the complicated pathogenesis of diseases;3)TCM has remarkable effect in inhibition of inflammation as well as in reducing enzymes and protecting liver. We also put forward suggestion and prospects in both clinical and basic research on regulating intestinal flora, anti-fibrosis and the compound prescription of TCM.

    参考文献
    相似文献
    引证文献
引用本文

胡义扬.中医药治疗非酒精性脂肪性肝病的优势与展望[J].世界中医药,2015,10(02).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2014-12-26
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2015-02-15
  • 出版日期:
文章二维码